You must account for other tissue related products that are being stored now too. That has been growing nicely....and I don't believe was a factor in 2012.
For the six months ended June 30, 2015, total revenue increased to approximately $2.70 million from $1.94 million, an increase of 39% over the same period of 2014. Revenues are generated primarily from three sources; new enrollment/processing fees, recurring storage fees (both from cord blood and cord tissue) and fees associated with other tissue related products. The increase in revenue is due to growth in recurring storage fees and fees from other tissue related products. For the six months ended June 30, 2015 recurring revenues accounted for 49% of total revenue. Cord remains focused on strategic organic growth which management anticipates will provide sustainable operating cash flows and net income.